Recombinant DNA Technology Global Market Report 2024

Description

Recombinant DNA Technology Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on recombinant dna technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for recombinant dna technology? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The recombinant dna technology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Product Type: Recombinant Protein Drugs; Vaccines; Genetically Modified Crops; Expression Systems; Cell and Gene Therapy; Gene Editing
2) By Component Type: Expression System; Cloning Vector
3) By Application Type: Food And Agriculture; Health And Disease; Environment; Other Application Types
4) By End-Use Type: Biotechnology And Pharmaceutical Companies; Academic And Government Research Institutes; Other End-Use Types
Companies Mentioned: Profacgen BioTech Corp.; Amgen Inc.; Novartis International AG; GenScript Biotech Corporation; Pfizer Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Recombinant DNA technology denotes the fusion of DNA molecules from diverse organisms, integrating them into a host organism to create new genetic combinations beneficial across scientific, medical, agricultural, and industrial domains. This technology plays a pivotal role in addressing health concerns by facilitating the development of novel medications and vaccines.

Within the realm of recombinant DNA technology, key product categories encompass recombinant protein drugs, vaccines, genetically modified crops, expression systems, cell and gene therapy, and gene editing. Notably, recombinant protein drugs serve crucial roles in biochemical analysis and medical diagnostics within human healthcare, including the production of antibodies, medicines, and vaccines. Renowned for their potency and rapid development compared to small molecules, these drugs are considered safer due to their reduced off-target adverse effects. This category comprises components like expression systems and cloning vectors. The extensive applications of recombinant DNA technology span various sectors such as food and agriculture, health and disease management, environmental interventions, and other diverse areas. This technology finds practical usage in biotechnology and pharmaceutical companies, academic and government research institutions, and various other end-use industries. Its impact is notably significant across a wide spectrum of fields and industries.

The recombinant DNA technology market research report is one of a series of new reports from The Business Research Company that provides recombinant DNA technology market statistics, including recombinant DNA technology industry global market size, regional shares, competitors with an recombinant DNA technology market share, detailed recombinant DNA technology market segments, market trends and opportunities, and any further data you may need to thrive in the recombinant DNA technology industry. This recombinant DNA technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The recombinant dna technology market size has grown strongly in recent years. It will grow from $816.9 billion in 2023 to $882.04 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. Historical growth can be credited to the escalating demands within the healthcare sector, the expansive growth of the biopharmaceutical industry, increased investments in research and development (R&D), and the emergence and adoption of personalized medicine. These factors collectively fueled growth during the historical period.

The recombinant dna technology market size is expected to see strong growth in the next few years. It will grow to $1214.85 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. Anticipated growth in the forecasted period is expected due to the upsurge in chronic diseases, the emergence of biotech startups, augmented funding within the biotech sector, the globalization of biotech markets, and increased consumer acceptance and education. These elements are projected to drive growth during the forecasted period.

The growth trajectory in the recombinant DNA technology market is primarily being steered by the escalating prevalence of chronic diseases. These enduring ailments, lasting a year or more and demanding ongoing medical attention, have spurred the adoption of recombinant DNA technology. Through the development of biopharmaceutical proteins and the advancement of gene therapy, this technology aims to combat these diseases. For instance, data shared by the World Health Organization (WHO) in April 2021 highlighted that noncommunicable diseases (NCDs) accounted for 71% of global deaths, with over 15 million yearly fatalities occurring between ages 30 and 69, mainly in low- and middle-income nations. This surge in chronic diseases is significantly propelling the growth of the recombinant DNA technology market.

Another substantial driver propelling the recombinant DNA technology market is the increasing advancement in genetically modified crops. Genetically modified (GM) crops, altered intentionally through biotechnological techniques, employ recombinant DNA (rDNA) technology to enhance their traits. This process involves isolating genes with desired characteristics, integrating recombinant DNA into crop cells, and rigorously testing and commercializing these crops. Notably, as per the United States Department of Agriculture's data in October 2023, a considerable percentage of soybean, corn, and cotton acreage in the US utilized genetically modified seeds, underscoring the pronounced growth in genetically modified crops, thereby driving the recombinant DNA technology market forward.

Technological advancement remains a pivotal trend in the recombinant DNA technology market, with leading companies focusing on innovative solutions to maintain their market position. For instance, in October 2021, Thermo Fisher Scientific introduced the Applied Biosystem QuantStudio Absolute Q-Digital PCR System. This pioneering technology streamlines digital PCR processes, ensuring highly precise genetic analysis within 90 minutes. The system's microfluidic array technology simplifies complex workflows, enhancing data accuracy while minimizing manual labor. Such advancements in technology are instrumental in shaping and driving the recombinant DNA technology market.

Moreover, major players within the recombinant DNA technology sector are actively engaged in developing new vaccines to sustain their market presence. For instance, Variation Biotechnologies Inc. launched PreHevbrio™ [Hepatitis B Vaccine (Recombinant)] in March 2022 in the United States. This vaccine, approved by the FDA in November 2021, incorporates essential hepatitis B surface antigens, ensuring a robust immune response when administered in a 3-dose series. The development and launch of such vaccines represent a significant stride within the recombinant DNA technology market.

In January 2022, Thermo Fisher Scientific, a prominent supplier based in the US specializing in scientific instrumentation, reagents, consumables, and software services, finalized the acquisition of PeproTech for a sum of $1.85 billion. This strategic acquisition aimed to complement Thermo Fisher's existing line of cell culture media products by integrating PeproTech's extensive portfolio of recombinant proteins. By combining these offerings, Thermo Fisher sought to deliver enhanced advantages to its customers through an integrated solution. PeproTech, Inc., the acquired company, is recognized for its expertise as a US-based developer and manufacturer of bioscience reagents, particularly renowned for its recombinant proteins.

Major companies operating in the recombinant dna technology market report are Profacgen BioTech Corp., Amgen Inc., Novartis International AG, GenScript Biotech Corporation, Pfizer Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Merck & Co. Inc., Biogen Inc., GlaxoSmithKline PLC, New England Biolabs Inc., Bayer CropScience, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals Inc., Gilead Sciences Inc., Moderna Inc., Vertex Pharmaceuticals Incorporated, CRISPR Therapeutics AG, Editas Medicine Inc., bluebird bio Inc., Illumina Inc., Qiagen N.V., Lonza Group AG, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Becton Dickinson and Company, Sartorius AG, Abcam PLC, Horizon Discovery Group PLC, Integrated DNA Technologies Inc., Twist Bioscience Corporation, Synthego Corporation, Codex DNA Inc., InvivoGen, Eurofins Scientific SE, Sarepta Therapeutics Inc., Sangamo Therapeutics Inc.

North America was the largest region in the recombinant DNA technology market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the recombinant dna technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the recombinant dna technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The recombinant DNA technology market includes revenues earned by entities by expression systems including mammalian, bacteria, yeast, and baculovirus / insect. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r12999

1. Executive Summary

2. Recombinant DNA Technology Market Characteristics

3. Recombinant DNA Technology Market Trends And Strategies

4. Recombinant DNA Technology Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Recombinant DNA Technology Market Size and Growth

5.1. Global Recombinant DNA Technology Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Recombinant DNA Technology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Recombinant DNA Technology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Recombinant DNA Technology Market Segmentation

6.1. Global Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Recombinant Protein Drugs
Vaccines
Genetically Modified Crops
Expression Systems
Cell and Gene Therapy
Gene Editing
6.2. Global Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Expression System
Cloning Vector
6.3. Global Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Food And Agriculture
Health And Disease
Environment
Other Application Types
6.4. Global Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Biotechnology And Pharmaceutical Companies
Academic And Government Research Institutes
Other End-Use Types

7. Recombinant DNA Technology Market Regional And Country Analysis

7.1. Global Recombinant DNA Technology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Recombinant DNA Technology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Recombinant DNA Technology Market

8.1. Asia-Pacific Recombinant DNA Technology Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Recombinant DNA Technology Market

9.1. China Recombinant DNA Technology Market Overview
9.2. China Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Recombinant DNA Technology Market

10.1. India Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Recombinant DNA Technology Market

11.1. Japan Recombinant DNA Technology Market Overview
11.2. Japan Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Recombinant DNA Technology Market

12.1. Australia Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Recombinant DNA Technology Market

13.1. Indonesia Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Recombinant DNA Technology Market

14.1. South Korea Recombinant DNA Technology Market Overview
14.2. South Korea Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Recombinant DNA Technology Market

15.1. Western Europe Recombinant DNA Technology Market Overview
15.2. Western Europe Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Recombinant DNA Technology Market

16.1. UK Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Recombinant DNA Technology Market

17.1. Germany Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Recombinant DNA Technology Market

18.1. France Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Recombinant DNA Technology Market

19.1. Italy Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Recombinant DNA Technology Market

20.1. Spain Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Recombinant DNA Technology Market

21.1. Eastern Europe Recombinant DNA Technology Market Overview
21.2. Eastern Europe Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Recombinant DNA Technology Market

22.1. Russia Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Recombinant DNA Technology Market

23.1. North America Recombinant DNA Technology Market Overview
23.2. North America Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Recombinant DNA Technology Market

24.1. USA Recombinant DNA Technology Market Overview
24.2. USA Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Recombinant DNA Technology Market

25.1. Canada Recombinant DNA Technology Market Overview
25.2. Canada Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Recombinant DNA Technology Market

26.1. South America Recombinant DNA Technology Market Overview
26.2. South America Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Recombinant DNA Technology Market

27.1. Brazil Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Recombinant DNA Technology Market

28.1. Middle East Recombinant DNA Technology Market Overview
28.2. Middle East Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Recombinant DNA Technology Market

29.1. Africa Recombinant DNA Technology Market Overview
29.2. Africa Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Recombinant DNA Technology Market Competitive Landscape And Company Profiles

30.1. Recombinant DNA Technology Market Competitive Landscape
30.2. Recombinant DNA Technology Market Company Profiles
- 30.2.1. Profacgen BioTech Corp.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Amgen Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Novartis International AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. GenScript Biotech Corporation
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Pfizer Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Recombinant DNA Technology Market Competitive Benchmarking

32. Global Recombinant DNA Technology Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Recombinant DNA Technology Market

34. Recombinant DNA Technology Market Future Outlook and Potential Analysis

34.1 Recombinant DNA Technology Market In 2028 - Countries Offering Most New Opportunities
34.2 Recombinant DNA Technology Market In 2028 - Segments Offering Most New Opportunities
34.3 Recombinant DNA Technology Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer